Avid Bioservices, Inc. (NASDAQ: CDMO)'s sale to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 per share in cash. If you are an Avid shareholder, click here to ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 31.15% ...
Our proprietary system currently recommends Altair Engineering (ALTR) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank. Studies have shown ...
Analysts expect adjusted earnings to reach $1.326 per share for the current fiscal year. Altair Engineering Inc. does not currently pay a dividend. AAII’s proprietary stock grades come with A+ ...
Therefore, the Zacks rating upgrade for Altair Engineering basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.